425: Strive & Semler Scientific Merger: Cautionary Outlook

Strive, Inc. and Semler Scientific, Inc. issue a cautionary statement regarding forward-looking aspects of their proposed business combination.

Summary

• Strive, Inc. and Semler Scientific, Inc. are engaged in a proposed business combination.
• This communication, reposted by Strive Board Member Pierre Rochard, serves as a cautionary statement regarding forward-looking statements related to the merger.
• The filing highlights potential strategic and financial benefits, including anticipated cost savings and strategic gains from the proposed transaction.
• Numerous risks and uncertainties are detailed, which could cause actual results to differ materially from anticipated outcomes.
• Key risks include termination of the merger agreement, failure to close, legal proceedings, unrealized benefits, integration difficulties, unexpected costs, diversion of management attention, and dilution from Strive's stock issuance.
• Investors are advised to review the Registration Statement on Form S-4 and other SEC filings for comprehensive information before making investment decisions.

Sentiment

Score: 5

Explanation: The filing is a standard cautionary statement regarding a proposed merger, highlighting both potential benefits and numerous risks without providing new financial performance data. The sentiment is neutral to cautious, emphasizing uncertainties.

Positives

• The proposed transaction is expected to yield strategic benefits for the combined company.
• Anticipated financial benefits include cost savings and strategic gains.
• The transaction is intended to positively impact the combined company's future financial performance.

Negatives

• The proposed transaction carries inherent risks and uncertainties that could prevent anticipated benefits from being realized.
• Integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The transaction may be more expensive or take longer to complete than anticipated due to unexpected factors.
• Management's attention may be diverted from ongoing business operations and opportunities during the merger process.
• Strive's issuance of additional shares of Class A common stock in connection with the transaction will cause dilution.

Risks

• Occurrence of any event, change, or circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement affecting the realization of benefits.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific, or the combined company, including unknown or unpredictable factors.

Future Outlook

The outlook and expectations for Strive and Semler Scientific regarding the proposed transaction, including strategic and financial benefits, the timing of closing, and successful integration, are subject to inherent risks and uncertainties. Actual results could differ materially from anticipated outcomes due to various factors, including economic conditions, regulatory changes, and integration challenges. Management's expectations are based on reasonable assumptions, but no assurance can be given that actual results will not differ materially from projected future results.

Management Comments

• Pierre Rochard, Board Member of Strive, Inc., reposted the communication on X.com on September 29, 2025, in connection with the proposed business combination.

Industry Context

NA

Stakeholder Impact

• Potential adverse reactions from customers of Strive or Semler Scientific.
• Changes to business or employee relationships for both companies, potentially resulting from the announcement or completion of the proposed transaction.
• Shareholders of Strive will experience dilution due to the issuance of additional Class A common stock.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register Class A common stock to be issued in the proposed transaction.
• The Registration Statement will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Keywords

Strive, Semler Scientific, merger, acquisition, business combination, SEC filing, Form 425, forward-looking statements, Bitcoin treasury, corporate governance, risk management